Avantor, Inc. (NYSE:AVTR – Get Free Report) saw a significant increase in short interest in the month of January. As of January 30th, there was short interest totaling 37,710,659 shares, an increase of 25.3% from the January 15th total of 30,097,069 shares. Based on an average trading volume of 13,997,283 shares, the days-to-cover ratio is presently 2.7 days. Currently, 5.6% of the shares of the stock are short sold. Currently, 5.6% of the shares of the stock are short sold. Based on an average trading volume of 13,997,283 shares, the days-to-cover ratio is presently 2.7 days.
Analyst Ratings Changes
Several analysts have issued reports on the stock. Morgan Stanley set a $10.00 price objective on shares of Avantor in a research report on Friday. UBS Group reaffirmed a “neutral” rating and set a $10.50 price target on shares of Avantor in a report on Thursday. Evercore ISI set a $10.00 price objective on shares of Avantor in a report on Wednesday, February 11th. Stifel Nicolaus set a $10.00 target price on Avantor in a research note on Thursday. Finally, Citigroup cut their price target on Avantor from $13.00 to $11.00 and set a “neutral” rating on the stock in a research note on Thursday. Three equities research analysts have rated the stock with a Buy rating, twelve have issued a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, the company currently has an average rating of “Hold” and a consensus price target of $11.84.
Insider Buying and Selling at Avantor
Institutional Trading of Avantor
Institutional investors and hedge funds have recently made changes to their positions in the stock. EverSource Wealth Advisors LLC raised its holdings in Avantor by 119.1% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 2,187 shares of the company’s stock valued at $29,000 after acquiring an additional 1,189 shares in the last quarter. Private Trust Co. NA boosted its stake in shares of Avantor by 46.2% in the 4th quarter. Private Trust Co. NA now owns 2,769 shares of the company’s stock valued at $32,000 after purchasing an additional 875 shares in the last quarter. Strategic Wealth Investment Group LLC bought a new stake in shares of Avantor in the 2nd quarter worth about $32,000. Los Angeles Capital Management LLC acquired a new stake in shares of Avantor during the 4th quarter worth about $32,000. Finally, FNY Investment Advisers LLC bought a new position in Avantor during the 2nd quarter valued at about $36,000. Institutional investors and hedge funds own 95.08% of the company’s stock.
Avantor Price Performance
Shares of Avantor stock traded up $0.05 on Monday, hitting $9.19. The company had a trading volume of 13,259,785 shares, compared to its average volume of 15,150,238. Avantor has a 52 week low of $8.90 and a 52 week high of $18.36. The company has a debt-to-equity ratio of 0.70, a current ratio of 1.78 and a quick ratio of 1.18. The company has a market cap of $6.26 billion, a PE ratio of -11.78, a PEG ratio of 3.62 and a beta of 0.94. The business has a 50-day simple moving average of $11.38 and a 200-day simple moving average of $12.20.
Avantor (NYSE:AVTR – Get Free Report) last issued its earnings results on Wednesday, February 11th. The company reported $0.22 earnings per share for the quarter, topping analysts’ consensus estimates of $0.21 by $0.01. The firm had revenue of $1.66 billion during the quarter, compared to analysts’ expectations of $1.64 billion. Avantor had a negative net margin of 8.09% and a positive return on equity of 10.45%. The firm’s revenue for the quarter was down 1.4% compared to the same quarter last year. During the same period last year, the firm posted $0.27 earnings per share. Avantor has set its FY 2026 guidance at 0.770-0.830 EPS. Research analysts expect that Avantor will post 1.06 EPS for the current fiscal year.
About Avantor
Avantor, Inc (NYSE:AVTR) is a global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company delivers essential solutions that support research, development, production and safety applications. Its product portfolio spans from high-purity chemicals and reagents to biologics and cell culture media, as well as lab equipment, consumables and custom manufacturing services.
Avantor’s offerings are organized across two primary segments.
Featured Articles
- Five stocks we like better than Avantor
- When to buy gold (mathematically)
- Nvidia CEO Issues Bold Tesla Call
- Trump & Musk’s Secret Bet on Silver — Exposed
- Is Elon Preparing for a Silver Shock?
- Trade this between 9:30 and 10:45 am EST
Receive News & Ratings for Avantor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avantor and related companies with MarketBeat.com's FREE daily email newsletter.
